Catalyst Pharmaceuticals Inc (CPRX)
21.26
-0.14
(-0.65%)
USD |
NASDAQ |
Apr 09, 13:05
Catalyst Pharmaceuticals Enterprise Value: 2.081B for April 8, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Corcept Therapeutics Inc | 7.054B |
| Ionis Pharmaceuticals Inc | 3.012B |
| Halozyme Therapeutics Inc | 7.996B |
| BridgeBio Pharma Inc | 6.783B |
| Recursion Pharmaceuticals Inc | 1.029B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 55.94M |
| Revenue (Quarterly) | 141.82M |
| Total Expenses (Quarterly) | 78.98M |
| EPS Diluted (Quarterly) | 0.44 |
| Gross Profit Margin (Quarterly) | 84.74% |
| Profit Margin (Quarterly) | 39.44% |
| Earnings Yield | 6.16% |
| Operating Earnings Yield | 7.35% |
| Normalized Earnings Yield | 5.985 |